Paediatric infectious diseases contribute significantly to global health challenges.
Conventional therapeutic interventions are not always suitable for children, as they are …

A major challenge in drug development is paediatric drug delivery; however, the problems
associated with drug administration in this population are manifold. Because of the highly …

Introduction The field of neonatal, infant and toddler pharmaceutical development is
constantly improving, however a lag still remains in comparison to older children and adults …

The quest for achieving optimal therapeutic outcomes in pediatric patients has evaded the
healthcare professionals for long and often lack of child specific dosage forms and the …

The neonatal and pediatric populations have long been neglected concerning the
development of oral dosage forms. For close to two decades, caregivers have had to adjust …

The development of antibiotics that are acceptable and easy for children to take and use is
highly desirable. As advocated by the World Health Organization, solid oral formulations …

For many years, children have been described as Btherapeutic orphans^ to indicate that
medicinal research, regulation, and formulation development has mainly focused on …

Introduction: Most conventional drug delivery systems are not acceptable for pediatric
patients as they differ in their developmental status and dosing requirements from other …

Paediatric drug delivery is a major challenge in drug development. Because of the
heterogeneous nature of the patient group, ranging from newborns to adolescents, there is a …

Children differ from adults in many aspects of pharmacotherapy, including capabilities for
drug administration, medicine-related toxicity, and taste preferences. It is essential that …